ArriVent BioPharma (NASDAQ:AVBP) Receives Buy Rating from HC Wainwright
HC Wainwright reaffirmed their buy rating on shares of ArriVent BioPharma (NASDAQ:AVBP – Free Report) in a research report released on Friday,Benzinga reports. The brokerage currently has a $39.00 price target on the stock. ArriVent BioPharma Stock Up 0.3 % Shares of AVBP stock opened at $21.87 on Friday. The firm has a fifty day […]
